» Articles » PMID: 33298237

Five-year Outcome of Peripherally Inserted Central Catheters in Adults: a Separated Infectious and Thrombotic Complications Analysis

Abstract

Objective: To assess infectious and thrombotic complications of peripherally inserted central catheters (PICCs) in adults.

Design: A 5-year prospective cohort study.

Setting: Tertiary-care teaching hospital in Seville, Spain.

Patients: Adult patients undergoing PICC insertion.

Methods: Catheter-associated bloodstream infection (CABSI) including catheter-related bloodstream infection (CRBSI), primary bacteremia (PB), and upper extremity deep vein thrombosis (UEDVT) were recorded. Independent predictors of complications were assessed by multivariate analysis.

Results: In total, 1,142 PICCs were inserted, with 153,191 catheter days (median, 79). Complications included 66 cases of CABSI (5.78%; 0.43‰ catheter days), 38 cases of CRBSI (3.33%; 0.25‰ catheter days), 28 cases of PB (2.45%; 0.18‰ catheter days), and 23 cases of UEDVT (2.01%; 0.15‰ catheter days). The median times to infection were 24, 41, and 60 days for CRBSI, PB, and UEDVT, respectively. Parenteral nutrition (odds ratio [OR], 3.40; 95% confidence interval [CI], 1.77-6.52) and admission to the hematology ward (OR, 4.90; 95% CI, 2.25-10.71) were independently associated with CRBSI and PB, respectively. Admission to the hematology ward (OR, 12.46; 95% CI, 2.49-62.50) or to the oncology ward (OR, 7.89; 95% CI, 1.77-35.16) was independently associated with UEDVT. The crude mortality rate was 24.8%. Only 2 patients died of complications.

Conclusions: PICCs showed a low rate of thrombotic and infectious complications. Compared to PB, CRBSI showed significantly different risk factors, a higher incidence density per catheter days, and a shorter median time to infection. Separate analyses of CRBSI and PB are more specific and clinically useful when analyzing infectious complications.

Citing Articles

Performance and safety of PowerPICC catheters and accessories: a prospective observational study.

Troubil M, Capozzoli G, Mussa B, Hodne M, Hoerauf K, Alsbrooks K BMJ Open. 2024; 14(9):e081288.

PMID: 39349374 PMC: 11448161. DOI: 10.1136/bmjopen-2023-081288.


Prevalence of PICC-related thrombosis in patients with hematological malignancies: a systematic review.

Dos Santos B, Gomes Beato B, Ferreira E, Braga F, Reis P, Silveira R Support Care Cancer. 2024; 32(7):462.

PMID: 38922487 DOI: 10.1007/s00520-024-08636-7.


Central venous access device terminologies, complications, and reason for removal in oncology: a scoping review.

Curtis K, Gough K, Krishnasamy M, Tarasenko E, Hill G, Keogh S BMC Cancer. 2024; 24(1):498.

PMID: 38641574 PMC: 11027380. DOI: 10.1186/s12885-024-12099-8.


Implementation of a vascular access team and an intravenous therapy programme: A first-year activity analysis.

Rosich-Soteras A, Bonilla-Serrano C, Llaurado-Gonzalez M, Fernandez-Bombin A, Trivino-Lopez J, Barcelo-Querol L J Vasc Access. 2024; 26(2):432-440.

PMID: 38205609 PMC: 11894895. DOI: 10.1177/11297298231220537.


Supportive care needs of adults living with a peripherally inserted central catheter (PICC) at home: a qualitative content analysis.

Sharp R, Xu Q, Pumpa R, Elliott L, Corsini N, Marker J BMC Nurs. 2024; 23(1):4.

PMID: 38163877 PMC: 10759691. DOI: 10.1186/s12912-023-01614-0.